## Core Concept
Lead time in medical screening refers to the length of time between the detection of a disease through screening and when it would have become apparent clinically. This concept is crucial in understanding the benefits and limitations of screening tests.

## Why the Correct Answer is Right
The correct answer defines lead time as the period gained between the early detection of a disease through screening and its clinical presentation. This period allows for earlier intervention, potentially improving outcomes. Lead time is a measure of the effectiveness of a screening test in detecting disease earlier than it would be detected clinically.

## Why Each Wrong Option is Incorrect
- **Option A:** This option is incorrect because it does not accurately define lead time. Without the specific text of option A, we can infer that any definition not matching the concept of time gained through early detection is incorrect.
- **Option B:** Similarly, this option is incorrect if it does not align with the definition of lead time as the interval between detection by screening and clinical presentation.
- **Option C:** This option is incorrect if it suggests a definition that does not pertain to the early detection of disease and the time gained thereby.

## Clinical Pearl / High-Yield Fact
A key point to remember is that lead time can sometimes create an illusion of increased survival even if the outcome in terms of mortality is not changed. For example, if a disease is detected earlier but the patient still dies at the same overall age, it might seem like survival has improved due to screening, even if the actual benefit in terms of life saved is zero. This concept is critical in evaluating the effectiveness of screening programs.

**Correct Answer: D. Lead time.**